Cathie's Ark Logo
Regeneron Pharmaceuticals, Inc. Logo

ARKG Holdings of Regeneron (REGN) - Updated Daily

TherapeuticsGenomics
Date
Direction
Shares
Fund Weight
Fund
September 29, 2022
SELL7.025k0.1979%ARKG
August 29, 2022
SELL516.0000.0113%ARKG
August 26, 2022
SELL1.730k0.036%ARKG
August 25, 2022
SELL139.0000.003%ARKG
August 24, 2022
SELL1.200k0.0262%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
1.14%$80.22b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
29🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
70$503.96
🎫ARK Ownership Percent
0.03%
Description
get in the ideas business. at regeneron we believe that when the right idea finds the right team, powerful change is possible. as we work together to discover, invent, and develop biopharmaceutical medicines, we’re creating whole new ways of thinking about science, manufacturing and commercialization. and whole new ways of thinking about health. so connect with us. tell us about you. learn more about our life-changing medicines. and join us, as we build a future we believe in. please visit www.regeneron.com/social-media-terms for more information on how to engage with regeneron on social media. an important note about privacy: regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. we do not interview candidates on google hangouts. any questions about job listings can be directed to candidatesupport@regeneron.com.
Website
regeneron.com

Other ETFs That Hold REGN

Ticker
NameWeight
IBBiShares Biotechnology ETF7.01%
AGNGGlobal X Aging Population ETF3.91%
XLVHealth Care Select Sector SPDR® Fund1.85%
ARKGARK Genomic Revolution ETF1.44%
XBISPDR® S&P Biotech ETF1.1%
QYLDGlobal X NASDAQ 100 Covered Call ETF0.72%
QQQInvesco QQQ Trust0.71%
SPYSPDR S&P 500 ETF Trust0.27%
LABUS&P Biotech Bull 3X Shares ETF0.198%

Research Notes and Commentary for REGN

No Research Notes Found for REGN